4//SEC Filing
Andrews Kurt J. 4
Accession 0001209191-18-002063
CIK 0001178879other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 5:13 PM ET
Size
9.5 KB
Accession
0001209191-18-002063
Insider Transaction Report
Form 4
Andrews Kurt J.
SVP, Human Resources
Transactions
- Exercise/Conversion
Stock Options (right to buy)
2018-01-02−10,000→ 65,000 totalExercise: $6.13From: 2017-02-01Exp: 2026-02-01→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2018-01-02$14.72/sh+10,000$147,191→ 44,737 total - Sale
Common Stock
2018-01-02$14.72/sh−10,000$147,191→ 34,737 total
Footnotes (3)
- [F1]The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2017.
- [F2]This price is the weighted average purchase price for the transactions reported on this line. The prices for the transactions reported on this line range from $14.12 to $15.16. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F3]This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $14.12 to $15.16. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Documents
Issuer
AMICUS THERAPEUTICS INC
CIK 0001178879
Entity typeother
Related Parties
1- filerCIK 0001636133
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 5:13 PM ET
- Size
- 9.5 KB